From October 1, 2023 to December 31, 2023, the company has repurchased 335,474 shares, representing 0.23% for $50 million. With this, the company has completed the repurchase of 7,455,695 shares, representing 5.29% for $463.38 million under the buyback announced on February 27, 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
191.4 USD | -0.08% |
|
-7.00% | +11.28% |
06-25 | Oppenheimer Downgrades ResMed to Market Perform From Outperform | MT |
06-24 | Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update | DJ |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.28% | 28.12B | |
+4.18% | 211B | |
+8.00% | 185B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.74% | 64.32B | |
+21.14% | 55.66B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Tranche Update on ResMed Inc.'s Equity Buyback Plan announced on February 27, 2014.